Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,255
Closed -$212K 1274
2019
Q3
$212K Sell
9,255
-2,996
-24% -$68.3K 0.01% 1114
2019
Q2
$298K Sell
12,251
-5,125
-29% -$105K 0.01% 1008
2019
Q1
$226K Sell
17,376
-517
-3% -$9.05K 0.01% 1165
2018
Q4
$270K Sell
17,893
-2,161
-11% -$55.9K 0.01% 984
2018
Q3
$788K Sell
20,054
-2,521
-11% -$114K 0.02% 678
2018
Q2
$1.11M Sell
22,575
-1,060
-4% -$60.1K 0.03% 548
2018
Q1
$1.41M Buy
23,635
+296
+1% +$19.7K 0.04% 488
2017
Q4
$1.84M Sell
23,339
-161
-0.7% -$13K 0.05% 422
2017
Q3
$1.97M Buy
23,500
+621
+3% +$44K 0.05% 387
2017
Q2
$1.5M Buy
22,879
+19
+0.1% +$1.29K 0.04% 470
2017
Q1
$1.66M Buy
22,860
+12,715
+125% +$835K 0.05% 438
2016
Q4
$595K Buy
+10,145
New +$536K 0.02% 749

Other funds holding ADNT

Oppenheimer & Co's ADNT Position: Q4 2019 in Review

Oppenheimer & Co sold out of Adient (ADNT) in Q4 2019, closing a stake of 9,255 shares — an estimated $212K sold.

Oppenheimer & Co first reported a position in ADNT in Q4 2016 and held it in 12 quarters. The position peaked at $1.97M in Q3 2017. 315 funds tracked by Wall St. Rank hold ADNT as of Q4 2019.

  • Oppenheimer & Co reported no remaining Adient position as of Q4 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 9,255 Adient shares in Q4 2019, an estimated $212K.
  • Oppenheimer & Co first reported a position in Adient in Q4 2016 and held it in 12 quarters.
  • Oppenheimer & Co's Adient position peaked at $1.97M in Q3 2017.
  • 315 funds tracked by Wall St. Rank held Adient as of Q4 2019.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.